Elliotts B

Manufacturer: QOL Medical, LLC
Effective date: 2012-08-22
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 6
Source: legacy-cache
Hydrated at: 2026-08-02 01:44:52

Label at a glance#

ProductElliotts B

Active ingredientsodium chloride, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate

Label structure13 sections

Indications and uses

Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.

Dosage and administration

See product labeling for methotrexate sodium and cytarabine. Elliotts B Solution is intended for intrathecal administration only. Elliotts B Solution does not contain antibacterial preservatives and introduction of contaminated solutions into the cerebrospinal fluid may have extremely serious consequences. Therefore, administration of intrathecal solutions should be accomplished as soon as possible after prepara...

Contacts and useful links#

PhoneLabel contact1-866-528-4750

Websitewww.elliottsbsolution.com

www.elliottsbsolution.com

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Elliotts B^® Solution is a sterile, nonpyrogenic, isotonic solution containing no bacteriostatic preservatives. Elliotts B Solution is a diluent for intrathecal administration of methotrexate sodium and cytarabine.

Each 10 mL of Elliotts B Solution contains:

Sodium Chloride, USP	73 mg
Sodium Bicarbonate, USP	19 mg
Dextrose, USP	8 mg
Magnesium Sulfate • 7H₂O, USP	3 mg
Potassium Chloride, USP	3 mg
Calcium Chloride • 2H₂O, USP	2 mg
Sodium Phosphate, dibasic • 7H₂O, USP	2 mg
Water for Injection, USP	qs 10 mL

Concentration of Electrolytes:

Sodium	149 mEq/liter	Bicarbonate	22.6 mEq/liter
Potassium	4.0 mEq/liter	Chloride	132 mEq/liter
Calcium	2.7 mEq/liter	Sulfate	2.4 mEq/liter
Magnesium	2.4 mEq/liter	Phosphate	1.5 mEq/liter

The formulae and molecular weights of the ingredients are:

INGREDIENT	MOLECULAR FORMULA	MOLECULAR WEIGHT
Sodium Chloride	NaCl	58.44
Sodium Bicarbonate	NaHCO₃	84.01
Dextrose	C₆H₁₂O₆	180.16
Magnesium Sulfate • 7H₂O	Mg₂SO₄ • 7H₂O	246.48
Potassium Chloride	KCl	74.55
Calcium Chloride • 2H₂O	CaCl₂ • 2H₂O	147.01
Sodium Phosphate, dibasic • 7H₂O	Na₂HPO₄ • 7H₂O	268.07

The pH of Elliotts B Solution is 6.0-7.5, and the osmolarity is 288 mOsmol per liter (calculated).

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Elliotts B Solution provides a buffered salt solution for use as a diluent for the intrathecal administration of methotrexate sodium and cytarabine. It has been demonstrated that Elliotts B Solution is comparable to cerebrospinal fluid in pH, electrolyte composition, glucose content, and osmolarity:

Comparison of Electrolyte Composition, pH and Nonelectrolytic Constituents of Elliotts B Solution and CSF

Solution	Na⁺ mEq/L	K⁺ mEq/L	Ca⁺⁺ mEq/L	Mg⁺⁺ mEq/L	HCO₃ ^- mEq/L	Cl^- mEq/L	pH	Phosphorus mg/dL	Glucose mg/dL
Cerebrospinal Fluid	117-137	2.3-4.6	2.2	2.2	22.9	113-127	7.31	1.2-2.1	45-80
Elliotts B Solution	149	4.0	2.7	2.4	22.6	132	6.0-7.5	2.3	80

The approximate buffer capacity of Elliotts B Solution is 1.1 X 10^-2 equivalents when the challenge solution is 0.01 N HCl and 7.8 X 10^-3 equivalents when the challenge solution is 0.01 N NaOH.1

Compatibility studies with methotrexate sodium and cytarabine indicate these drugs are physically compatible with Elliotts B Solution.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

None known.

WARNINGS

WARNINGS SECTION

Intrathecal administration of drugs such as methotrexate sodium and cytarabine should be performed by personnel skilled in the technique of lumbar puncture under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents. The labeling for methotrexate sodium and cytarabine should be consulted.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

Particular attention should be taken to assure the maintenance of sterile technique throughout the procedure. (See DOSAGE AND ADMINISTRATION.)

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

No standard mutagenicity or carcinogenicity studies have been conducted with Elliotts B Solution.

Usage in Pregnancy

PREGNANCY SECTION

Pregnancy Category C

All components of Elliotts B Solution are normal body constituents. Animal reproduction studies have not been conducted with Elliotts B Solution.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Adverse reactions may occur with any given intrathecal injection due to the chemotherapy or the technique of intrathecal administration. (See product labeling for methotrexate sodium and cytarabine.)

Preservative-free methotrexate sodium and cytarabine should be used to minimize adverse reactions due to preservatives.

If an adverse reaction does occur, discontinue the administration, evaluate the patient, institute appropriate therapeutic countermeasures and, if possible, save the remainder of the unused solution(s) for examination.

DRUG ABUSE AND DEPENDENCE

DRUG ABUSE AND DEPENDENCE SECTION

There is no potential for drug abuse or drug dependence.

OVERDOSAGE

OVERDOSAGE SECTION

Elliotts B Solution is a diluent. In the event of a drug, fluid or solute overload following administration, evaluate the patient's condition, and institute appropriate corrective treatment. (See product labeling for methotrexate sodium and cytarabine.)

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

See product labeling for methotrexate sodium and cytarabine.

Elliotts B Solution is intended for intrathecal administration only. Elliotts B Solution does not contain antibacterial preservatives and introduction of contaminated solutions into the cerebrospinal fluid may have extremely serious consequences. Therefore, administration of intrathecal solutions should be accomplished as soon as possible after preparation.

A sterile filter-needle should be used to withdraw the contents of the ampule.

Intrathecal drug products should be inspected visually for particulate matter and discoloration prior to administration.

Preparation and Administration Precautions

SPL UNCLASSIFIED SECTION

Elliotts B Solution is a diluent for the cytotoxic anticancer agents, methotrexate sodium and cytarabine. Care should be exercised in the handling and preparation of infusion solutions with these products. (See product labeling for methotrexate sodium and cytarabine.)

HOW SUPPLIED

HOW SUPPLIED SECTION

NDC	SIZE
67871-007-10	10 mL ampule

Elliotts B Solution is available in single-use clear glass ampules, packaged 10 ampules per box.

Store at controlled room temperature, 20º-25ºC (68º-77ºF) [See USP].

Preservative Free. Discard unused portion. Use only if solution is clear and ampule is intact.

Distributed by:
QOL Medical, LLC
Vero Beach, FL 32963
1-866-528-4750

www.elliottsbsolution.com

REFERENCES:

REFERENCES SECTION

1. Cradock JC, et al. Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate. American Journal of Hospital Pharmacy (1978); 35:402.

Rev. 12/11
Part No. 210

PACKAGING

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Ampule labeling:

Ampule Labeling

Box labeling:

Box Labeling

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
67871-007-10	2019-11-27	C162847	48780-1	9855d018-dd0c-cd31-e053-dbdaa90ab51a	ELLIOTTS B ® SOLUTION (buffered intrathecal electrolyte/dextrose injection) Rx Only

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67871-007	ELLIOTTS B (SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE) INJECTION [QOL MEDICAL, LLC]	6	Legacy NDC	20121023_b1e83fb1-7f51-41b7-a1eb-495414bbf1f2.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
67871-007-10	ML - Milliliter	67871-007	9c97a8d2-a7da-498c-b0d9-91a997abd667	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
anhydrous dextrose	ACTIVE INGREDIENT	5SL0G7R0OK	6
calcium chloride	ACTIVE INGREDIENT	M4I0D6VV5M	6
magnesium sulfate	ACTIVE INGREDIENT	DE08037SAB	6
potassium chloride	ACTIVE INGREDIENT	660YQ98I10	6
sodium bicarbonate	ACTIVE INGREDIENT	8MDF5V39QO	6
sodium chloride	ACTIVE INGREDIENT	451W47IQ8X	6
sodium phosphate	ACTIVE INGREDIENT	SE337SVY37	6
anhydrous dextrose	ACTIVE MOIETY	5SL0G7R0OK	6
bicarbonate ion	ACTIVE MOIETY	HN1ZRA3Q20	6
calcium cation	ACTIVE MOIETY	2M83C4R6ZB	6
chloride ion	ACTIVE MOIETY	Q32ZN48698	6
magnesium cation	ACTIVE MOIETY	T6V3LHY838	6
phosphate ion	ACTIVE MOIETY	NK08V8K8HR	6
potassium cation	ACTIVE MOIETY	295O53K152	6
Water	INACTIVE INGREDIENT	059QF0KO0R	6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

Elliotts B
sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate
sodium chloride
sodium cation
chloride ion
sodium bicarbonate
bicarbonate ion
anhydrous dextrose
magnesium sulfate
magnesium cation
potassium chloride
potassium cation
calcium chloride
calcium cation
sodium phosphate
phosphate ion
Water

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
67871-007	67871-007-01, 67871-007-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
sodium chloride	451W47IQ8X	ACTIB
sodium bicarbonate	8MDF5V39QO	ACTIB
anhydrous dextrose	5SL0G7R0OK	ACTIB
magnesium sulfate	DE08037SAB	ACTIB
potassium chloride	660YQ98I10	ACTIB
calcium chloride	M4I0D6VV5M	ACTIB
sodium phosphate	SE337SVY37	ACTIB
Water	059QF0KO0R	IACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020577-001	ELLIOTTS B SOLUTION	CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL		RLD, RS	1996-09-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020577-001	ELLIOTTS B SOLUTION	0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML	INJECTABLE / INTRATHECAL	RLD, RS	1996-09-27	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
6b61a6f9-0cc7-47bf-a600-ae8bb89a9501			b1e83fb1-7f51-41b7-a1eb-495414bbf1f2	2012-08-22	Warnings, Adverse reactions	Exact identifier spl id: 6b61a6f9-0cc7-47bf-a600-ae8bb89a9501 spl set id: b1e83fb1-7f51-41b7-a1eb-495414bbf1f2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.